Aravive (FRA:VE11) Other Operating Expense : €-0.00 Mil (TTM As of Sep. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Aravive Other Operating Expense?

Aravive's Other Operating Expense for the three months ended in Sep. 2023 was €-0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2023 was €-0.00 Mil.

Aravive's quarterly Other Operating Expense declined from Mar. 2023 (€0.00 Mil) to Jun. 2023 (€0.00 Mil) and declined from Jun. 2023 (€0.00 Mil) to Sep. 2023 (€-0.00 Mil).

Aravive's annual Other Operating Expense declined from Dec. 2020 (€-0.00 Mil) to Dec. 2021 (€-0.00 Mil) but then increased from Dec. 2021 (€-0.00 Mil) to Dec. 2022 (€0.00 Mil).

Aravive Other Operating Expense Historical Data

The historical data trend for Aravive's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aravive Other Operating Expense Chart

Aravive Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Operating Expense

Get a 7-Day Free Trial

Aravive Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Other Operating Expense	Get a 7-Day Free Trial															-	-	-	-	-

Aravive Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.00 Mil.

Aravive Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Aravive's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Aravive Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aravive Inc (FRA:VE11) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

3730 Kirby Drive, River Oaks Tower, Suite 1200, Houston, TX, USA, 77098

Website

https://www.aravive.com

Aravive Inc is a clinical-stage biopharmaceutical company. It focuses on developing treatments designed to halt the progression of life-threatening diseases, including cancer and fibrosis. The company pipeline product Batiraxcept (formerly AVB-500) which is an ultra-high affinity decoy protein that binds to GAS6 and thereby prevents AXL signaling to inhibit metastasis and tumor growth and restore sensitivity to anti-cancer agents. Batiraxcept is currently being evaluated in multiple clinical trials.

Aravive Headlines

No Headlines